The Changes of T lymphocyte subsets before and after Chemotherapy on 30 Ovarian Cancer Patients
DU Hong-y
Abstract
DU Hong-y
Abstract
Objective:To explore the changes of T lymphocyte subsets(CD3+、CD4+、CD8+、CD4+/CD8+)before and after chemotherapy on malignant Ovarian Cancer patients after their operations.Methods :After their operations, by flow cytometry, to detect the changes of quantities and ratios of T lymphocyte subsets in Ovarian Cancer patients before and during two- three weeks after the chemotherapy. Results :Compared the level before the chemotherapy, during two- three weeks after the chemotherapy, the levels of CD3+ and CD4+ cells were significantly higher,the ratio of CD4+/CD8+ increased, CD8+ cells had no obvious changes in different stage. Conclusion:The chemotherapy on malignant Ovarian Cancer patients is helpful in the recovery of the patients' immune functions of the cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the changes of T lymphocyte subsets(CD3+、CD4+、CD8+、CD4+/CD8+)before and after chemotherapy on malignant Ovarian Cancer patients after their operations.Methods :After their operations, by flow cytometry, to detect the changes of quantities and ratios of T lymphocyte subsets in Ovarian Cancer patients before and during two- three weeks after the chemotherapy. Results :Compared the level before the chemotherapy, during two- three weeks after the chemotherapy, the levels of CD3+ and CD4+ cells were significantly higher,the ratio of CD4+/CD8+ increased, CD8+ cells had no obvious changes in different stage. Conclusion:The chemotherapy on malignant Ovarian Cancer patients is helpful in the recovery of the patients' immune functions of the cells.
Key concepts: Medicine, Ovarian cancer, CD8, Chemotherapy, CD3, Lymphocyte subsets, Immune system, Flow cytometry